News for Salarius Pharmaceuticals, Inc. (SLRX)

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.4% on Tuesday. Following the market opening Tuesday, the Dow traded down 0.02...

California-based DURECT Corporation (DRRX) is up over 267 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Salarius Pharmaceuticals (SLRX) recently received a notification from Nasdaq indicating an extension to meet compliance with Nasdaq Listing Rule 5550(b)(1) by t

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. ( SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company receiv

Salarius Pharmaceuticals (SLRX) has received an additional extension from Nasdaq to meet crucial listing requirements by late July/early August 2025. The co

Salarius Pharmaceuticals (SLRX) has reported promising findings from two recent animal studies that highlight the significance of inhibiting lysine-demethylase

Phase 1/2 clinical study evaluating seclidemstat in patients with MDS and CMML is progressing with updates expected later this year Company continues to advanc

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (”œIPA” or the ”œCompany”), an AI-powered biotherapeutics company, today announced the appointment of Jon Lie

Shares of Lennar Corporation LEN rose sharply in today's pre-market trading after the company reported mixed results for the second quarter. Lennar reported qu...

Decoy Therapeutics has announced a key addition to its Scientific Advisory Board, heralding a new chapter as it prepares to merge with Salarius Pharmaceuticals

**media[577165]**

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of novel peptide

Salarius Pharmaceuticals (SLRX) reports FY GAAP EPS of -$5.79. Cash reserves at $2.4M, projected to support operations until late Q2 2025.

Utah-based Sintx Technologies, Inc. (SINT) is up over 87 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

HOUSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. ( SLRX) announces that patient enrollment will resume in the investigator-initiated

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.85%

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 150 points on Monday. The Dow traded up 0.64% to 42,206.46 while t...

Salarius Pharmaceuticals and Decoy Therapeutics announce merger agreement, creating new company led by current leadership teams.

U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.13% to 41,992.95 while the NA...